Introduction
reported during this time were brief episodes of polyarthralgia. Laboratory tests showed a normal creatin-AA amyloidosis is a complication of chronic inflamine level, albumin concentration at 1.79 g/dl, heavy matory diseases including Crohn's disease, rheumatoid proteinuria (3 g/day), no haematuria, antinuclear antiarthritis, ankylosing spondylitis, and juvenile rheumatbody titres of 1/500, no anti-DNA antibodies, no oid arthritis. In contrast to the past, today it is less monoclonal gammopathy, and normal levels of comfrequently associated with chronic infectious diseases plement factors. The CRP level was high (6.7 mg/dl ) such as tuberculosis. AA amyloidosis has also been despite the presence of a nephrotic syndrome. No reported in cancer, Muckle-Wells disease and familial infectious disease was found. Although there were no Mediteranean fever (FMT ) where the incidence differs signs of active SLE, a diagnosis of membranous between less than 10% for Armeniens and Arabs and glomerulopathy was entertained and renal biopsy was over 30% among Turks and Sephardic Jews.
performed which revealed massive glomerular and Conversely, AA amyloidosis is not a classic comvascular Congo-red-positive areas exhibiting green plication of SLE, and fewer than 20 cases have been birefringence under polarized light, staining with reported in English worldwide, although cases of SLE anti-AA antibodies but not with other sera ( Figure 1 ). with monoclonal gammopathy may be complicated by Optic microscopy and immunofluorescence study AL amyloidosis.
detected no SLE nephritis. Electron-microscopic We observed one unusual patient with SLE analysis was not performed. complicated by AA amyloidosis.
The patient received colchicine (1 mg/day). Subsequently, clinical and biological findings suggested hepatic and intestinal amyloid involvement. Renal Case insufficiency began 2 months later and progressed in 6 months to end-stage renal disease; the patient was then A 55-year-old woman with a 4-year history of SLE without renal involvement was admitted with a nephrotic syndrome. SLE had been diagnosed when she was 51 years old, following a 10-year history of isolated dermatological problems: she presented with non-destructive and non-deforming polyarthritis, skin rash, and iliac thrombophlebitis. Laboratory investigation revealed high titres of antinuclear (1/1000) and anti-DNA (82 U/ml ) antibodies. There was no haematuria, no proteinuria, the creatinine level was normal, and the C-reactive protein level (CRP) was very high (3.6 mg/dl ); lupus anticoagulant and IgG anticardiolipid (34 U GPL) were also present. She met four of the American Rheumatism Association's criteria for SLE, and was treated with oral corticosteroid.
She was readmitted to our service 4 years later with amyloidosis [12, 16 ] , and hepatomegaly without proteinuria [15] . The delay between the diagnosis of SLE and the onset of symptomatic AA amyloidosis varied from 1 to 35 years. In nearly half the observations, as in our case, AA amyloidosis appeared within 5 years after onset of SLE.
The sex ratio deviates from the usual female predominance in SLE i.e.10:1; approximately 40% of the reported cases of SLE complicated by AA amyloidosis are men.
In the reported cases,the clinical activity of SLE varied greatly. However, CRP was high in all cases when it was tested. This was true even in cases with the nephrotic syndrome, as was also observed in our patient [6, 7] . were also high and paradoxically they remained high even in the nephrotic syndrome [6, 7] , although Rosenthal and Franklin [19] had shown that SAA treated by haemodialysis thrice weekly until she died concentrations are often normal in AA amyloidosis from sepsis 6 months later. Autopsy was not with nephrotic syndrome, presumably due to urinary performed.
loss. Persistently elevated concentrations of SAA in nephrotic patients suggest very high compensatory hepatic synthesis of SAA.
Discussion
There is a growing body of evidence that a high concentration of the acute phase reactant SAA, is a major predisposing factor for AA amyloidosis. This SLE was the most likely cause of the AA amyloidosis documented in this 55-year-old Caucasian woman. constitutes a necessary, but not sufficient, condition in the complex multifactorial process thats ultimately Inherited, infectious, and inflammatory diseases, which are known to cause AA amyloidosis, were excluded leads to amyloidogenesis.
The SAA concentration in SLE and chronic with reasonable certainty. To our knowledge, fewer than 20 such cases have been reported in the English inflammatory diseases has been studied by De Beer et al. [20] . They found very high SAA concentrations literature since 1956 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Experimental studies, e.g. histopathological examination of the kidneys of in patients with rheumatoid arthritis, juvenile chronic arthritis, and Crohn's disease. They were highly correl-(NZB/NZW )F1 mice which develop SLE-like disease with immune-complex glomerulonephritis has consist-ated with disease activity. In contrast SAA concentrations are only slighly elevated in patients with ulcerative ently failed to demonstrate amyloid deposits [18] .
The type of amyloidosis has not always been ascer-colitis and most patients with SLE, even in those with very active disease. The concentrations of CRP in tained among the few cases with lupus and amyloidosis described so far [1] [2] [3] [4] [5] . The Wright test (stability with patients with SLE follow a similar pattern. Like SAA, CRP is often normal even in the presence of active KMNO 4 , a characteristic of AA amyloidosis, but of limited specificy ) was positive in some [6] [7] [8] 15, 16 ] . disease. These differences with respect to SAA and CRP concentrations between SLE and rheumatoid Further, the aetiological link between SLE and AA amyloidosis is not entirely convincing in some of these arthritis, may largely account for the difference in incidence of AA amyloidosis between these two reports since the patients in addition to lupus had further diseases that are themselves often associated conditions. Garcia-Tobaruela et al.
[15] observed improvement with AA amyloidosis, notably ankylosing spondylitis, rheumatoid arthritis and lymphoma [1,2,4]. In one of symptoms when colchicine treament was instituted, but our patient received colchicine treatment without further report, Huston et al. [6 ] described a 43-yearold Egyptian with SLE amyloidosis; despite no per-any benefit. They is actually no information as to whether immunosuppressants are effective. sonal or family FMT history, it is uncertain whether FMF is totally excluded.
Nevertheless no explanation other than SLE can be found in the remaining cases, and AA amyloidosis was References well characterized by immunohistochemical studies in 
